Monalizumab (Anti-Human CD159a)
中文名称：Monalizumab (Anti-Human CD159a)
Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors.
点击购买Monalizumab (Anti-Human CD159a)的同型对照：
产品质控
批次：
纯度：
99%
蛋白浓度： 10.7mg/ml
内毒素： ＜1EU/mg
99
CD markers抑制剂选择性比较
生物活性
| 产品描述 | Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors. |
|---|
抗体信息
| CAS号 | 1228763-95-8 |
|---|---|
| 分子量 | 150 kDa |
| 配制 | PBS Buffer, PH 7.4 |
| 推荐同型对照 | Human IgG4-Kappa |
| 应用 | Monalizumab (Anti-Human CD159a) |
| 纯化 | Protein G |
| 除菌 | 0.2 μM filtered |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
技术支持
如果有其他问题，请给我们留言。
* 必填项
